Back to search
Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma trials you may qualify forThis project proposes to establish a prospective, multicenter, randomized, controlled clinical study to compare the safety and efficacy of Intralesional Rituxim…
Extranodal marginal zone B-cell lymphoma (EMZL) is the most common lymphoma of the ocular adnexa (OA), accounting for approximately 60%. As a special part of th…
Objective of this trial is to establish the efficacy of an upfront targeted therapy consisting of Chlamydophila psittaci (Cp)-eradicating therapy with prolonged…
This phase II trial studies how well ultra low dose orbital radiation therapy works in treating patients with stage I-IV low grade (indolent) B-cell lymphoma or…